女性与金黄色葡萄球菌菌血症患者死亡率:系统评价与荟萃分析
该研究为系统评价与荟萃分析,检索MEDLINE、Embase和Web of Science自建库至2023年4月26日,纳入评估成人金黄色葡萄球菌菌血症(SAB)的随机或观察性研究(患者≥200例、报告90天或更早死亡率、按性别分层)。共纳入89项研究(132 582例患者,女性50 258例[37.9%],男性82 324例[62.1%])。81项研究(109 828例)的未校正数据显示女性死亡率高于男性(合并OR 1.12,95%CI 1.06-1.18);32项研究(95 469例)的校正数据(校正其他患者特征和治疗变量)显示女性死亡风险同样升高(合并校正OR 1.18,95%CI 1.11-1.27)。未发现发表偏倚证据。结论认为女性SAB患者死亡风险高于男性,需进一步研究潜在机制。
要点
- 成人SAB患者中,女性死亡率高于男性:未校正合并OR 1.12(95%CI 1.06-1.18),校正后合并OR 1.18(95%CI 1.11-1.27)。
- 纳入89项研究共132 582例患者,女性占37.9%(50 258例),男性占62.1%(82 324例)。
- 未校正死亡率数据来自81项研究(109 828例),校正数据来自32项研究(95 469例)。
- 未发现发表偏倚证据。
- 作者结论:女性SAB患者死亡风险高于男性,需进一步研究潜在机制。
适用人群与场景
- 纳入标准:评估成人SAB的随机或观察性研究,纳入患者≥200例,报告SAB后90天或更早死亡率,并按性别分层报告死亡率。
- 排除标准:特定亚人群研究(如透析、重症监护病房、癌症患者)以及纳入多种微生物菌血症但未报告SAB特异性数据的研究。
研究设计与关键结果
- 研究类型:系统评价与荟萃分析;检索MEDLINE、Embase和Web of Science自建库至2023年4月26日,共检索到5339项研究,最终纳入89项(132 582例患者;女性50 258例[37.9%],男性82 324例[62.1%])。
- 未校正死亡率数据来自81项研究(109 828例患者),女性患者死亡率高于男性患者(合并OR 1.12;95%CI 1.06-1.18)。
- 校正其他患者特征和治疗变量后的死亡率数据来自32项研究(95 469例患者),女性相对男性死亡风险同样升高(合并校正OR 1.18;95%CI 1.11-1.27)。
- 未发现发表偏倚证据。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,纳入随机或观察性研究。
- 采用纽卡斯尔-渥太华质量评估量表评估偏倚风险和质量。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:女性SAB患者死亡风险高于男性,需进一步研究潜在机制。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Staphylococcus aureus is the leading cause of death due to bacterial bloodstream infection. Female sex has been identified as a risk factor for mortality in S aureus bacteremia (SAB) in some studies, but not in others.
OBJECTIVE: To determine whether female sex is associated with increased mortality risk in SAB.
DATA SOURCES: MEDLINE, Embase, and Web of Science were searched from inception to April 26, 2023.
STUDY SELECTION: Included studies met the following criteria: (1) randomized or observational studies evaluating adults with SAB, (2) included 200 or more patients, (3) reported mortality at or before 90 days following SAB, and (4) reported mortality stratified by sex. Studies on specific subpopulations (eg, dialysis, intensive care units, cancer patients) and studies that included patients with bacteremia by various microorganisms that did not report SAB-specific data were excluded.
DATA EXTRACTION AND SYNTHESIS: Data extraction and quality assessment were performed by 1 reviewer and verified by a second reviewer. Risk of bias and quality were assessed with the Newcastle-Ottawa Quality Assessment Scale. Mortality data were combined as odds ratios (ORs).
MAIN OUTCOME AND MEASURES: Mortality at or before 90-day following SAB, stratified by sex.
RESULTS: From 5339 studies retrieved, 89 were included (132 582 patients; 50 258 female [37.9%], 82 324 male [62.1%]). Unadjusted mortality data were available from 81 studies (109 828 patients) and showed increased mortality in female patients compared with male patients (pooled OR, 1.12; 95% CI, 1.06-1.18). Adjusted mortality data accounting for additional patient characteristics and treatment variables were available from 32 studies (95 469 patients) and revealed a similarly increased mortality risk in female relative to male patients (pooled adjusted OR, 1.18; 95% CI, 1.11-1.27). No evidence of publication bias was encountered.
CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis, female patients with SAB had higher mortality risk than males in both unadjusted and adjusted analyses. Further research is needed to study the potential underlying mechanisms.
参考来源
- Westgeest AC, Lambregts MMC, Ruffin F, et al. Female Sex and Mortality in Patients with Staphylococcus aureus Bacteremia: A Systematic Review and Meta-analysis. JAMA Netw Open. 2024. PMID: 38411961. doi:10.1001/jamanetworkopen.2024.0473
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。